Sanofi and GlaxoSmithKline said clinical trials of their COVID19 vaccine showed an insufficient immune response in older people, delaying its launch to late next year and marking a setback in the global fight against the pandemic.from Top Business News- News18.com
Read The Rest:timesnownews...
Sanofi And GSK Delay COVID-19 Vaccine, Marking Setback For Global Fight
Reviewed by Team Exprssnews
on
December 11, 2020
Rating:
No comments: